š Kona Peptides 2026 ā Clinician-Prescribed BPC-157, TB-500, GHK-Cu & 12 More Compounds. The Telehealth Model That’s Changing How Serious Biohackers Access Peptides.
Kona Peptides strips out the waiting rooms, the gatekeeping, and the gray-market guesswork. You complete an online intake, a licensed US clinician reviews it, and a licensed US compounding pharmacy ships your compound ā prescribed, legal, and verified. Here’s the full breakdown of what’s available, what it costs, and whether the model holds up to scrutiny.
The Peptide Access Problem ā And Why It’s Been Getting Worse
For most of the past decade, if you wanted BPC-157, TB-500, or GHK-Cu, you had two choices: pay a functional medicine doctor several thousand dollars for an in-person consultation, or order from a gray-market research chemical supplier with no prescription, no clinical oversight, and no guarantee the compound in the vial matches the label.
Neither option is good. The first is prohibitively expensive and geographically limited. The second carries real risk ā unverified purity, unknown manufacturing standards, and zero legal protection if something goes wrong. The peptide community has been quietly navigating this gap for years. (If research-use peptides without a prescription requirement are what you’re looking for, see our OnyxBioLabs review ā a US-based supplier with third-party COA verification.)
Telehealth peptide platforms are the third path ā and they’ve matured significantly in 2025ā2026. The model: licensed clinicians review patient intakes online, prescribe appropriate compounds when clinically indicated, and licensed US compounding pharmacies prepare and ship the medication. Legal, clinician-supervised, and dramatically more accessible than traditional functional medicine.
Kona Peptides, operated by Compound Technologies, Inc., is one of the cleaner implementations of this model ā with a catalog breadth that covers five distinct therapeutic categories and a pricing structure built for ongoing protocols, not one-off purchases.
What Is Kona Peptides?
Kona Peptides is a prescription peptide telehealth platform operated by Compound Technologies, Inc. The service connects patients with licensed US clinicians who review medical intakes and, when clinically appropriate, issue prescriptions that are filled by a licensed US compounding pharmacy and shipped directly to the patient’s door.
The platform offers 14+ compounds across five therapeutic categories ā recovery and repair, energy and longevity, immune support, focus and clarity, and gut health ā plus seven curated stacks that pair compounds for synergistic goals. Individual compounds are available as vials or prefilled pens (3 mL cartridge). Select compounds are available as nasal spray or oral capsules.
Contact: support@konapeptides.com. Patient messaging is available through the secure patient portal for existing prescriptions.
ā Start Your Kona Peptides Intake ā 50% Off First MonthHow Kona Peptides Works ā 4 Steps
5 Therapeutic Categories at Kona Peptides
Kona Peptides Key Compounds ā WHY & HOW
BPC-157 is a 15-amino acid peptide derived from a gastric protein sequence. It’s among the most studied compounds in the peptide space, with animal research showing accelerated healing of tendons, ligaments, bone, gut lining, and muscle tissue ā while simultaneously reducing inflammation at the injury site.
For athletes dealing with chronic tendinopathies, post-surgical healing, or recurring GI inflammation, BPC-157 addresses tissue repair at a biological level that conventional NSAIDs and rest simply don’t reach. If you need BPC-157 for laboratory research purposes rather than clinical prescription, see our OnyxBioLabs supplier review for the research-use alternative.
A systematic review published in Orthopedic Sports Medicine (2024) examined BPC-157 in musculoskeletal healing and found consistent preclinical evidence of accelerated tendon and ligament repair, reduced inflammatory markers, and improved mechanical tensile strength in treated tissue versus control.
Dr. Pat Taylor’s comprehensive BPC-157 research review notes the compound is available at Kona Peptides in both injectable vial form (systemic/tendon focus) and oral capsule form (gut lining specific) ā making delivery method matching to target tissue a meaningful clinical consideration.
First month: $99.50 (reg. $199)
TB-500 (Thymosin Beta-4 fragment) promotes the upregulation of actin ā a structural protein essential to cell mobility, proliferation, and differentiation. Where BPC-157 targets local tissue repair through growth factor stimulation, TB-500 works systemically, promoting cell migration to injury sites throughout the body.
The combination of BPC-157 + TB-500 ā sold as Kona’s “Wolverine” stack ā is one of the most popular peptide pairings in the recovery space precisely because the mechanisms complement rather than duplicate each other.
Research reviewed at NCBI / PubMed demonstrates Thymosin Beta-4’s role in promoting angiogenesis (new blood vessel formation), reducing cardiac and skeletal muscle inflammation post-injury, and accelerating wound closure in multiple tissue models.
Kona Peptides offers TB-500 both as a standalone vial and within the Wolverine combination product. For users dealing with widespread recovery needs ā multiple joints, post-surgical healing, or accumulated soft-tissue damage ā the systemic nature of TB-500 makes it a logical pairing with BPC-157’s more localized mechanism.
First month (Wolverine vial BPC-157 + TB-500): $89.50 (reg. $179)
GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is a naturally occurring tripeptide-copper complex that declines significantly with age ā from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60. This decline corresponds directly with reduced skin repair capacity, collagen degradation, and impaired wound healing.
Beyond skin, GHK-Cu has documented gene-regulatory activity ā it activates over 30 genes related to tissue repair and anti-inflammatory response, and suppresses 16+ genes associated with inflammation and oxidative stress. It’s one of the broadest-acting compounds in the catalog.
A review in Biomolecules (NCBI) documents GHK-Cu’s capacity to stimulate collagen and glycosaminoglycan synthesis, improve skin elasticity and density, reduce fine-line depth, and accelerate dermal wound repair ā with effects confirmed in both in vitro and human clinical studies.
Kona Peptides offers GHK-Cu as a standalone vial, within the GLOW combination vial (GHK-Cu + BPC-157 + TB-500), and as GHK-Cu Cream for topical application. The injectable form achieves systemic levels the topical alone cannot ā relevant for patients targeting both skin repair and systemic anti-aging effects.
First month standalone: $104.50 (reg. $209) | GLOW vial: $114.50 (reg. $229)
MOTS-c is a mitochondria-derived peptide encoded within the mitochondrial genome ā making it unique in peptide pharmacology. It acts as a metabolic regulator, promoting glucose metabolism, improving insulin sensitivity, reducing fatty acid accumulation, and enhancing physical endurance through mitochondrial pathway activation.
Unlike most energy-targeting supplements that operate through neurostimulation, MOTS-c works at the cellular bioenergetics level ā addressing the fundamental machinery of how cells produce and use energy as it deteriorates with age.
A landmark study published in Cell Metabolism (NCBI) found that MOTS-c administration in obese mice produced significant improvements in glucose regulation, reduced diet-induced insulin resistance, and increased physical endurance ā with effects mediated through AMPK pathway activation in skeletal muscle.
For patients experiencing metabolic decline, chronic fatigue, or exercise-induced energy insufficiency that conventional interventions haven’t addressed, MOTS-c represents one of the few compounds targeting mitochondrial function directly rather than downstream symptoms.
First month: $109.50 (reg. $219)
Thymosin Alpha-1 (TĪ±1) is a naturally occurring thymic peptide with the longest clinical history of any compound in the Kona Peptides catalog. It has been used clinically in Europe and Asia for decades for immune modulation in chronic viral infections, autoimmune conditions, and post-cancer immune reconstitution.
As thymic function declines with age ā reducing immune surveillance and T-cell diversity ā TĪ±1 provides direct thymic signaling support, enhancing dendritic cell function, natural killer cell activity, and regulatory T-cell balance.
A meta-analysis in the International Immunopharmacology Journal (NCBI) reviewed Thymosin Alpha-1’s clinical applications and found consistent evidence of improved T-cell activation, enhanced interferon-gamma production, and favorable safety profiles across chronic hepatitis B, hepatitis C, and sepsis populations.
For health-optimizers targeting immune resilience, chronic viral susceptibility, or post-illness immune recovery, Thymosin Alpha-1 is one of the best-evidenced compounds in the catalog ā with a clinical track record that predates the modern peptide telehealth industry by decades.
First month: $114.50 (reg. $229) | Pen: $179.50 (reg. $359)
Kona Peptides Curated Stacks
Stacks combine two complementary compounds in a single checkout ā and include a permanent 15% off every payment, making them more cost-effective than buying the same compounds individually on ongoing protocols.
Kona Peptides Pricing ā Full Breakdown
Kona Peptides applies a 50% first-month discount to all individual products. Stacks carry a 15% off every payment ā making them more economical for patients who intend to run multi-month protocols, which is standard clinical practice for most of the compounds in the catalog.
Kona Peptides: Green Flags & Red Flags
What Kona Peptides Patients Are Saying
On-site verified buyer reviews at konapeptides.com show consistently strong satisfaction around compound quality, shipping speed, and care team responsiveness. Product listings carry between 170 and 617 verified reviews. Here’s a representative cross-section:
Our Kona Peptides Verdict
Kona Peptides closes the gap between the supplement shelf and the functional medicine clinic in a way that’s genuinely accessible. The prescription model ā licensed clinician intake, licensed US compounding pharmacy ā puts it in a different category from both OTC supplements and gray-market research chemical suppliers. That’s not a marketing claim; it’s a structural difference with real implications for patient safety and compound quality.
The catalog depth is unmatched among telehealth peptide platforms we’ve evaluated. Fourteen-plus compounds covering five therapeutic categories, available in multiple delivery formats, with curated stacks at a permanent 15% discount ā this is a platform built for patients running serious multi-month protocols, not one-off purchases.
The transparency gaps are the main concern: no published company address, no public COA access, no independent Trustpilot profile. These are meaningful omissions for a cash-pay medical service. The on-site verified reviews are strong, but independent third-party ratings would significantly strengthen credibility.
Bottom line: If you’ve plateaued on conventional supplements and you’re serious about clinician-supervised peptide therapy with US-compounded compounds, Kona Peptides is among the most complete and credibly structured options available in 2026. The 50% first-month discount makes the initial intake risk-appropriate for most patients. Start with a single compound matched to your primary goal, complete the intake honestly, and let the clinical review process work as designed.
Not ready for injectable peptides yet? If cognitive performance is your starting goal, VapoMind is a no-prescription nootropic worth reviewing first. For raw research peptide supply with full COA transparency, OnyxBioLabs is the supplier we recommend. Both reviewed in full on WellnessPro360.
Kona Peptides FAQ ā Straight Answers
Prescription required: All Kona Peptides compounds require a licensed clinician intake and prescription. Completing an intake does not guarantee approval ā clinician determination is based on individual patient suitability.
Not FDA-approved: Compounded medications prepared by a licensed US pharmacy under 503A are not FDA-approved finished drug products. They have not been reviewed by the FDA for safety, efficacy, or quality.
Not for self-administration without guidance: Injectable peptides should only be administered by or under the guidance of a licensed healthcare professional familiar with your specific protocol, dosing schedule, and health history.
Individual results vary: Clinical research supporting individual compounds does not guarantee specific outcomes. Peptide therapy responses vary by individual, protocol, dose, and health status.
Who should not proceed: Pregnant or nursing individuals, people under 18, or those with active cancer, autoimmune conditions, or serious chronic disease should consult their specialist before any peptide protocol.
Affiliate disclosure: WellnessPro360 may earn a commission if you access Kona Peptides through links in this post, at no cost to you. This does not influence our editorial analysis. Pricing and product availability reflect information reviewed in October 2026 ā confirm current terms at konapeptides.com before starting your intake.
š Related Reviews on WellnessPro360
š¬ OnyxBioLabs Official 2026 ā US-based research peptide supplier. BPC-157, NAD+, Tirzepatide. HPLC 99%+ purity, COA verified. Best for research-use access without a prescription requirement.
š§ VapoMind Official 2026 ā Daily nootropic capsule for memory, focus & clarity. Ginkgo Biloba, Bacopa, Alpha-GPC, Phosphatidylserine. No prescription needed. From $49/bottle. Good entry point before prescription peptide therapy.
š All Peptide Therapy Reviews ā Full category index: research suppliers, telehealth platforms, injectable stacks, and supplement alternatives compared side-by-side.
Pingback: Nervecept Official 2026 | Proven Natural Nerve Support Formula
Pingback: PressureCalmX Official 2026 | Proven Botanical Blood Pressure Support